454631730
01 Jul 2020
Japan Novartis announces MET inhibitor Tabrecta approved in Japan for advanced non-small cell lung cancer with METex14, Japan
Severity: Notice
Message: Undefined variable: region
Filename: views/login_detail_view_new_V1.php
Line Number: 393
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.